|
WO2011079047A1
|
|
Methods for reducing the occurrence of preterm delivery and other pregnancy-related conditions
|
|
WO2009036355A1
|
|
Transdermal hormone spray
|
|
WO2009036311A1
|
|
Transdermal, alcohol-free, pharmaceutical compositions
|
|
WO2009032699A1
|
|
Anti-proliferative combinations
|
|
US2009035385A1
|
|
Compositions including iron
|
|
US2009035370A1
|
|
Dosage form and method of use
|
|
WO2008150741A1
|
|
Controlled release dopamine agonist compositions
|
|
WO2008144143A1
|
|
Endometriosis treatment
|
|
WO2008112388A1
|
|
Spatial arrangement of particles in a drinking device for oral delivery of pharmaceuticals
|
|
TW200843802A
|
|
Compositions for improving gastrointestinal nutrient and drug absorption
|
|
US2008181932A1
|
|
Compositions for oral delivery of pharmaceuticals
|
|
WO2008079868A1
|
|
Clonidine composition and method of use
|
|
US2008161376A1
|
|
Method of treating candida isolates
|
|
WO2008073779A2
|
|
Compositions and methods for treating seizures
|
|
US2008299050A1
|
|
Topical therapies for oral mucositis and other conditions
|
|
WO2008030830A2
|
|
Sustained-release composition and method of use thereof
|
|
US2008003262A1
|
|
Compositions and therapeutic methods of use
|
|
WO2007134158A2
|
|
Granules comprising calcium carbonate, a binder and a porosity increasing agent, processes of manufacturing, use in therapy
|
|
CN101405049A
|
|
Intravaginal medicament applicators
|
|
MX2008011894A
|
|
Intravaginal medicament applicators.
|
